Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
21/08/2025
After falling for six consecutive trading days, the stock price of AI application software PALANTIR rose 2% in pre-market trading.
Latest
3 m ago
Zhongji Anruike and Zhonghang You Southern Storage and Transportation cooperate to jointly build a green methanol supply network.
3 m ago
Zhejiang Shibao (01057.HK) uses part of the unused funds raised for cash management.
3 m ago
On August 21, Yunxiang Technology (02488.HK) spent approximately HK$1.9676 million to repurchase 174,000 shares.
3 m ago
According to the result of overseas drug inspection, the National Medical Products Administration issued the "Announcement of the National Medical Products Administration on Suspending the Import Clearance Record of Loratadine Active Pharmaceutical Ingredient by Vasudha Pharm Chem Limited from India" (No. 22 of 2019) on March 20, 2019, deciding to suspend the issuance of import clearance certificate for the product. After Vasudha Pharm Chem Limited has made improvements, they have submitted an application to the National Medical Products Administration for the resumption of the import clearance record of Loratadine active pharmaceutical ingredient and relevant supplementary registration applications. In accordance with the Drug Administration Law of the People's Republic of China and the Regulations for Overseas Inspection Management of Drugs and Medical Devices, the National Medical Products Administration has decided to resume the import of Loratadine active pharmaceutical ingredient (English name: Loratadine) produced by Vasudha Pharm Chem Limited after the relevant supplementary application has been approved.
3 m ago
Announcement of the State Drug Administration on the resumption of the import customs clearance filing for loratadine raw materials by Fast Pharma Company
See all latest
